Detalhe da pesquisa
1.
2023 White Paper on Recent Issues in Bioanalysis: ISR for ADA Assays, the Rise of dPCR vs qPCR, International Reference Standards for Vaccine Assays, Anti-AAV TAb Post-Dose Assessment, NanoString Validation, ELISpot as Gold Standard (Part 3 - Recommendations on Gene Therapy, Cell Therapy, Vaccines Immunogenicity & Technologies; Biotherapeutics Immunogenicity & Risk Assessment; ADA/NAb Assay/Reporting Harmonization).
Bioanalysis
; 16(7): 77-119, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38389403
2.
The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C.
Hum Vaccin Immunother
; 19(2): 2235238, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37529944
3.
Development and Validation of Two Optimized Multiplexed Serologic Assays for the 9-Valent Human Papillomavirus Vaccine Types.
mSphere
; 8(2): e0096221, 2023 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36926984
4.
Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU).
Hum Vaccin Immunother
; 18(1): 1-14, 2022 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34726574
5.
Development and Validation of a Sensitive and Robust Multiplex Antigen Capture Assay to Quantify Streptococcus pneumoniae Serotype-Specific Capsular Polysaccharides in Urine.
mSphere
; 7(4): e0011422, 2022 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35913133
6.
2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 & CAR-T Immunogenicity; PCR & Vaccine Assay Performance; ADA Assay Comparability & Cut Point Appropriateness (Part 3 - Recommendations on Gene Therapy, Cell Therapy, Vaccine Assays; Immunogenicity of Biotherapeutics and Novel Modalities; Integrated Summary of Immunogenicity Harmonization).
Bioanalysis
; 14(11): 737-793, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35578991
7.
Three-Year Follow-up of 2-Dose Versus 3-Dose HPV Vaccine.
Pediatrics
; 147(1)2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33386332
8.
Characterization of a human immunodeficiency virus type 1 V3 deletion mutation that confers resistance to CCR5 inhibitors and the ability to use aplaviroc-bound receptor.
J Virol
; 83(8): 3798-809, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19193800
9.
Raising the Bar: Using Simulation to Advance Staff Competency Regarding the Patient Experience.
J Nurses Prof Dev
; 36(5): 294-298, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32890185
10.
Optimization and validation of a microcolony multiplexed opsonophagocytic killing assay for 15 pneumococcal serotypes.
Bioanalysis
; 12(14): 1003-1020, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32686954
11.
Enhanced antipneumococcal antibody electrochemiluminescence assay: validation and bridging to the WHO reference ELISA.
Bioanalysis
; 12(19): 1363-1375, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32975436
12.
A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants.
Pediatr Infect Dis J
; 39(8): 763-770, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32639460
13.
Effects of partial deletions within the human immunodeficiency virus type 1 V3 loop on coreceptor tropism and sensitivity to entry inhibitors.
J Virol
; 82(2): 664-73, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17977968
14.
V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.
PLoS Pathog
; 3(8): e117, 2007 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-17722977
15.
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults.
Hum Vaccin Immunother
; 15(3): 530-539, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30648919
16.
Live attenuated Listeria monocytogenes expressing HIV Gag: immunogenicity in rhesus monkeys.
Vaccine
; 25(42): 7470-9, 2007 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-17854955
17.
Replication-competent variants of human immunodeficiency virus type 2 lacking the V3 loop exhibit resistance to chemokine receptor antagonists.
J Virol
; 81(18): 9956-66, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17609282